查看購物車
  • English
  • Japanese
  • Korean
細胞和基因治療市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按類型、服務、規模、服務供應商、轉染試劑、最終用戶和地區分類
市場調查報告書
商品編碼
1938233

細胞和基因治療市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按類型、服務、規模、服務供應商、轉染試劑、最終用戶和地區分類

Cell and Gene Therapy Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Service, Scale, Service Providers, Transfection Reagents, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 300 Pages | 訂單完成後即時交付

價格
細胞和基因治療市場規模預計將從2024年的53億美元成長到2031年的257.8億美元，2025年至2031年的複合年成長率（CAGR）為25.5%。慢性病和遺傳性疾病的日益增多、細胞和基因治療生產外包的快速普及以及監管核准和商業化的激增是推動細胞和基因治療市場規模擴張的重要因素。此外，下一代基因編輯工具的開發預計將在不久的將來引領細胞和基因治療的新趨勢。

人工智慧和自動化正在對細胞和基因治療（CGT）領域產生革命性的影響。為了克服當前的挑戰，學術界正在利用人工智慧進行預測建模，並結合自動化流程改進來最佳化規劃。史丹佛大學醫學院的CRISPR-GPT是一種人工智慧技術，可以自動規劃基因編輯相關的實驗，將試驗的時間從數月縮短到數天。同樣，耶魯大學醫學院的生成式人工智慧模型可以設計新型DNA序列，透過開啟或關閉基因來開發更安全的基因治療載體，用於臨床前研究。

自動化與人工智慧完美契合，因為它能減少生產過程中的人工干預。在這方面，Cellares公司的Cell Shuttle系統利用機器人技術實現了CAR-T細胞的全自動生產，純度提升，處理速度提高至多10倍。這些進步帶來了顯著優勢。根據《生物程序國際》報導，自動化透過提高合規性和柔軟性，可將自體細胞和基因治療的成本降低30-50%。人工智慧與自動化的協同作用加速了細胞和基因治療的發展，並確保了越來越多的慢性病患者能夠平等地獲得治療。這使其成為細胞和基因治療市場的重要趨勢。

最終用戶洞察

按最終用戶分類，細胞和基因治療市場可分為受託研究機構(CRO)、製藥和生物製藥公司以及學術和研究機構。截至 2024 年，製藥和生物製藥公司佔據了最大的市場。成長推動要素包括醫療保健支出不斷增加以及政府推出有利於臨床試驗的法規，這些因素對尋求多樣化遺傳背景以開發個人化醫療的跨國公司極具吸引力。遺傳疾病的日益普遍和製造成本的下降正在刺激國內藥品生產，從而促進從學名藥向 CAR-T 療法等先進治療方法的過渡。自 2014 年以來，各國監管協調，例如日本引入再生醫學有條件批准核准，降低了投資風險。在日本成功開發 CAR-T 療法的主要企業包括Astellas製藥和武田製藥。這兩家公司都透過對白血病患者的臨床試驗，在日本開發了 CAR-T 候選藥物。日本也透過FUJIFILM細胞動力有限公司在iPS細胞技術的應用上主導。在中國，百濟神州和傳奇生物（與強生公司合作）已將BCMA標靶治療商業化用於治療多發性骨髓瘤，受益於上海龐大的患者群體和政府支持的叢集，推動了細胞和基因治療市場的成長。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：細胞與基因治療市場的市場狀況

  • 價值鏈分析
  • 供應鏈分析
    • 製造商和供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • PEST分析
  • 人工智慧（AI）的影響
  • 細胞療法或技術藍圖
  • 永續性與ESG趨勢
  • 專利分析
  • 法律規範

第3章 競爭情勢

  • 主要企業進行企業標竿分析
  • 2024年主要企業市佔率分析
  • 市場集中度

第4章 細胞與基因治療市場－主要市場動態

  • 市場促進因素
    • 慢性病和遺傳性疾病增多
    • 細胞和基因治療製造外包業務快速成長
    • 監管核准和商業化激增
  • 市場限制
    • 開發和治療高成本
    • 嚴峻的監理挑戰
    • 缺乏技術熟練的專業人員和基礎設施
  • 市場機遇
    • 企業策略舉措
    • 政府支持措施
    • 增加對研發和臨床試驗的投入
  • 未來趨勢
    • 人工智慧 (AI) 與自動化的融合
    • 下一代基因編輯工具的開發
    • 同種異體移植和現成療法的興起
  • 促進因素和抑制因素的影響

5. 細胞與基因治療市場－全球市場分析

  • 細胞與基因療法市場收入（2021-2031 年）
  • 細胞與基因治療市場預測與分析

6. 細胞和基因治療市場按類型分類的收入分析

  • 細胞與基因治療市場預測與分析（按類型）
    • 細胞療法
      • 細胞療法：細胞和基因療法市場—收入，2021-2031年
    • 基因治療
      • 基因療法：細胞和基因療法市場—收入，2021-2031年

7. 細胞和基因治療市場按服務分類的收入分析

  • 細胞及基因治療市場預測及服務分析
    • 製程開發
      • 製程開發：細胞與基因治療市場－收入，2021-2031年
    • cGMP生產
      • cGMP 生產：細胞和基因治療市場 - 收入，2021-2031 年
    • 監管服務
      • 監管服務：細胞與基因治療市場－收入，2021-2031年
    • 生物檢測服務
      • 生物檢測服務：細胞和基因治療市場 - 收入，2021-2031 年

8. 細胞和基因治療市場規模收入分析

  • 細胞與基因治療市場規模預測與分析
    • 商業化前/研發/生產
      • 商業化前/研發生產：細胞與基因治療市場－收入，2021-2031年
    • 商業規模生產
      • 商業化規模生產：細胞與基因治療市場－收入，2021-2031年

9. 細胞和基因治療市場按服務供應商的收入分析

  • 細胞和基因治療市場預測及服務供應商分析
    • CDMO
      • CDMO：細胞和基因治療市場－收入，2021-2031年
    • CMO
      • CMO：細胞與基因治療市場－收入，2021-2031年

10. 細胞與基因治療市場收入分析－轉染試劑

  • 細胞與基因治療市場預測與分析（按轉染試劑分類）
    • 以聚合物為基礎的轉染試劑
      • 聚合物為基礎的轉染試劑：細胞和基因治療市場－收入，2021-2031年
    • 基於脂質的轉染試劑
      • 以脂質為基礎的轉染試劑：細胞與基因治療市場－收入，2021-2031年
    • 病毒轉導增強子
      • 病毒轉導增強劑：細胞和基因治療市場－收入，2021-2031年
    • 其他轉染試劑
      • 其他轉染試劑：細胞和基因治療市場－收入，2021-2031年

第11章 細胞和基因治療市場按最終用戶分類的收入分析

  • 細胞及基因治療市場預測及最終用戶分析
  • 學術和研究機構

第12章：細胞與基因治療市場－區域分析

  • 北美洲
    • 按類型
    • 按類型分類的細胞療法
    • 依基因治療類型
    • 服務
    • 規模
    • 服務提供者
    • 轉染試劑
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 英國市場
    • 德國市場
    • 法國市場
    • 義大利市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太地區的其他國家
  • 中東和非洲市場
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 南美洲和中美洲
    • 南美洲和拉丁美洲市場
      • 巴西市場
      • 阿根廷市場
      • 其他南美洲和中美洲及其他區域市場

第13章 細胞與基因治療市場產業概況

第14章 細胞與基因治療市場－主要企業概況

  • CRISPR Therapeutics
  • Horizon Discovery Group plc.
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Integrated DNA Technologies Inc.
  • QIAGEN NV
  • Takara Bio Inc
  • Synthego Holdings LLC
  • GenScript Biotech Corporation
  • Editas Medicine Inc

第15章附錄

Product Code: TIPRE00020854

The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing prevalence of chronic and genetic diseases, the rapid popularity of outsourcing cell and gene therapy manufacturing, and surging regulatory approvals and commercialization are noteworthy factors contributing to the expansion of the cell and gene therapy market size. Additionally, the development of next-generation gene editing tools is projected to bring new cell and gene therapy market trends in the near future.

AI and automation are making a revolutionary impact in the realm of CGT. This academic field has been using AI for predictive modeling, in association with automated process improvement for planning, to overcome current challenges. CRISPR-GPT at Stanford Medicine, an AI technology capable of automating the planning of experiments related to editing genes, has reduced the "time burden of trial-and-error" phases from months to mere days. Similarly, the Yale School of Medicine's generative AI model designs "new DNA sequences" to switch genes "on" and "off" for the development of safer "gene therapy vectors" in preclinical studies.

Automation works well with AI as it reduces human involvement in the manufacturing process. In this regard, the Cell Shuttle system by Cellares relies on robotics for completeCAR-T cell manufacturing with higher purity and an increased processing speed of up to 10 times. These developments provide significant benefits. According to BioProcess International, automation can reduce autologous CGT cost by 30-50% through enhanced compliance and flexibility. The synergy between AI and automation fast-tracks CGT, which ensures equal treatment access for those affected by rising chronic diseases, thereby emerging as a significant trend in the cell and gene therapy market.

End User-Based Insights

Based on end user, the cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest cell and gene therapy market share in 2024. The driving forces of growth include increasing expenditures in the healthcare sector and favorable government regulations, which accelerate clinical trials; these offer attractions to MNCs looking for varying genetic backgrounds for the development of personalized medications. The growing number of genetic ailments as well as fewer costs of manufacturing act as stimuli for the domestic manufacturing of medications, thus facilitating a transition from generics to more advanced therapies like CAR-T. Improved regulatory harmonization among the countries, with Japan introducing conditional approval of regenerative therapies since 2014, reduces the risks associated with investment. Key players who have successfully developed CAR-T therapies in Japan include the country's own Astellas Pharma and Takeda Pharmaceutical companies, who have developed CAR-T candidates in Japan through clinical trials in patients with leukemia. Japan has the lead in adopting iPS cell technology through the Fujifilm Cellular Dynamics company. In China, Beigene and Legend Biotech (in collaboration with Johnson & Johnson) have commercialized BCMA-targeted therapies for multiple myeloma, benefiting from massive patient pools and government-backed bioclusters in Shanghai, thereby fueling the cell and gene therapy market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the cell and gene therapy market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Cell and Gene Therapy Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 PEST Analysis
  • 2.5 Impact of Artificial Intelligence (AI)
  • 2.6 Cell Therapy or Technology Roadmap
  • 2.7 Sustainability and ESG Trends
  • 2.8 Patent Analysis
  • 2.9 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2024 - By Key Players
  • 3.3 Market Concentration

4. Cell and Gene Therapy Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
    • 4.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surging Regulatory Approvals and Commercialization
  • 4.2 Market Restraints
    • 4.2.1 High Costs of Development and Treatment
    • 4.2.2 Stringent Regulatory Challenges
    • 4.2.3 Shortage Of Skilled Professionals and Infrastructure
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Companies
    • 4.3.2 Supportive Government Initiatives
    • 4.3.3 Rising Investments in Research & Development and Clinical Trials
  • 4.4 Future Trends
    • 4.4.1 Integration of AI and Automation
    • 4.4.2 Development of Next-Generation Gene Editing Tools
    • 4.4.3 Rise of Allogeneic and Off-The-Shelf Therapies
  • 4.5 Impact of Drivers and Restraints

5. Cell and Gene Therapy Market - Global Market Analysis

  • 5.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • 5.2 Cell and Gene Therapy Market Forecast and Analysis

6. Cell and Gene Therapy Market Revenue Analysis -Type

  • 6.1 Cell and Gene Therapy Market Forecasts and Analysis by Type
    • 6.1.1 Cell Therapy
      • 6.1.1.1 Overview
      • 6.1.1.2 Cell Therapy: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.2 Gene Therapy
      • 6.1.2.1 Overview
      • 6.1.2.2 Gene Therapy: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

7. Cell and Gene Therapy Market Revenue Analysis -Service

  • 7.1 Cell and Gene Therapy Market Forecasts and Analysis by Service
    • 7.1.1 Process Development
      • 7.1.1.1 Overview
      • 7.1.1.2 Process Development: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.2 cGMP Manufacturing
      • 7.1.2.1 Overview
      • 7.1.2.2 cGMP Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.3 Regulatory Services
      • 7.1.3.1 Overview
      • 7.1.3.2 Regulatory Services: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.4 Bioassay Services
      • 7.1.4.1 Overview
      • 7.1.4.2 Bioassay Services: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

8. Cell and Gene Therapy Market Revenue Analysis - Scale

  • 8.1 Cell and Gene Therapy Market Forecasts and Analysis by Scale
    • 8.1.1 Pre-commercial/R and D Manufacturing
      • 8.1.1.1 Overview
      • 8.1.1.2 Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.2 Commercial Scale Manufacturing
      • 8.1.2.1 Overview
      • 8.1.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

9. Cell and Gene Therapy Market Revenue Analysis -Service Providers

  • 9.1 Cell and Gene Therapy Market Forecasts and Analysis by Service Providers
    • 9.1.1 CDMOs
      • 9.1.1.1 Overview
      • 9.1.1.2 CDMOs: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.2 CMOs
      • 9.1.2.1 Overview
      • 9.1.2.2 CMOs: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

10. Cell and Gene Therapy Market Revenue Analysis - Transfection Reagents

  • 10.1 Cell and Gene Therapy Market Forecasts and Analysis by Transfection Reagents
    • 10.1.1 Polymer-based Transfection Reagents
      • 10.1.1.1 Overview
      • 10.1.1.2 Polymer-based Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.2 Lipid-based Transfection Reagents
      • 10.1.2.1 Overview
      • 10.1.2.2 Lipid-based Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.3 Viral Transduction Enhancers
      • 10.1.3.1 Overview
      • 10.1.3.2 Viral Transduction Enhancers: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.4 Other Transfection Reagents
      • 10.1.4.1 Overview
      • 10.1.4.2 Other Transfection Reagents: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

11. Cell and Gene Therapy Market Revenue Analysis - By End User

  • 11.1 Cell and Gene Therapy Market Forecasts and Analysis by End User
    • 11.1.1 Contract Research Organizations
      • 11.1.1.1 Overview
      • 11.1.1.2 Contract Research Organizations: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
    • 11.1.2 Pharmaceutical and Biopharmaceutical Companies
      • 11.1.2.1 Overview
      • 11.1.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)
  • 11.1. Academic and Research Institutes
      • 11.1.3.1 Overview
      • 11.1.3.2 Academic and Research Institutes: Cell and Gene Therapy Market -Revenue, 2021-2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Cell and Gene Therapy Market Overview
    • 12.1.2 North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.1.3 North America: Cell and Gene Therapy Market- By Segmentation
      • 12.1.3.1 Type
      • 12.1.3.2 Cell Therapy For Type
      • 12.1.3.3 Gene Therapy For Type
      • 12.1.3.4 Service
      • 12.1.3.5 Scale
      • 12.1.3.6 Service Providers
      • 12.1.3.7 Transfection Reagents
      • 12.1.3.8 End User
    • 12.1.4 North America: Cell and Gene Therapy Market Breakdown by Countries
      • 12.1.4.1 United States Market
        • 12.1.4.1.1 United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.1.2 United States: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.1.2.1 Type
          • 12.1.4.1.2.2 Cell Therapy For Type
          • 12.1.4.1.2.3 Gene Therapy For Type
          • 12.1.4.1.2.4 Service
          • 12.1.4.1.2.5 Scale
          • 12.1.4.1.2.6 Service Providers
          • 12.1.4.1.2.7 Transfection Reagents
          • 12.1.4.1.2.8 End User
      • 12.1.4.2 Canada Market
        • 12.1.4.2.1 Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.2.2 Canada: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.2.2.1 Type
          • 12.1.4.2.2.2 Cell Therapy For Type
          • 12.1.4.2.2.3 Gene Therapy For Type
          • 12.1.4.2.2.4 Service
          • 12.1.4.2.2.5 Scale
          • 12.1.4.2.2.6 Service Providers
          • 12.1.4.2.2.7 Transfection Reagents
          • 12.1.4.2.2.8 End User
      • 12.1.4.3 Mexico Market
        • 12.1.4.3.1 Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.1.4.3.2 Mexico: Cell and Gene Therapy Market- By Segmentation
          • 12.1.4.3.2.1 Type
          • 12.1.4.3.2.2 Cell Therapy For Type
          • 12.1.4.3.2.3 Gene Therapy For Type
          • 12.1.4.3.2.4 Service
          • 12.1.4.3.2.5 Scale
          • 12.1.4.3.2.6 Service Providers
          • 12.1.4.3.2.7 Transfection Reagents
          • 12.1.4.3.2.8 End User
  • 12.2 Europe
    • 12.2.1 Europe Cell and Gene Therapy Market Overview
    • 12.2.2 Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.2.3 Europe: Cell and Gene Therapy Market- By Segmentation
      • 12.2.3.1 Type
      • 12.2.3.2 Cell Therapy For Type
      • 12.2.3.3 Gene Therapy For Type
      • 12.2.3.4 Service
      • 12.2.3.5 Scale
      • 12.2.3.6 Service Providers
      • 12.2.3.7 Transfection Reagents
      • 12.2.3.8 End User
    • 12.2.4 Europe: Cell and Gene Therapy Market Breakdown by Countries
      • 12.2.4.1 United Kingdom Market
        • 12.2.4.1.1 United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.1.2 United Kingdom: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.1.2.1 Type
          • 12.2.4.1.2.2 Cell Therapy For Type
          • 12.2.4.1.2.3 Gene Therapy For Type
          • 12.2.4.1.2.4 Service
          • 12.2.4.1.2.5 Scale
          • 12.2.4.1.2.6 Service Providers
          • 12.2.4.1.2.7 Transfection Reagents
          • 12.2.4.1.2.8 End User
      • 12.2.4.2 Germany Market
        • 12.2.4.2.1 Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.2.2 Germany: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.2.2.1 Type
          • 12.2.4.2.2.2 Cell Therapy For Type
          • 12.2.4.2.2.3 Gene Therapy For Type
          • 12.2.4.2.2.4 Service
          • 12.2.4.2.2.5 Scale
          • 12.2.4.2.2.6 Service Providers
          • 12.2.4.2.2.7 Transfection Reagents
          • 12.2.4.2.2.8 End User
      • 12.2.4.3 France Market
        • 12.2.4.3.1 France: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.3.2 France: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.3.2.1 Type
          • 12.2.4.3.2.2 Cell Therapy For Type
          • 12.2.4.3.2.3 Gene Therapy For Type
          • 12.2.4.3.2.4 Service
          • 12.2.4.3.2.5 Scale
          • 12.2.4.3.2.6 Service Providers
          • 12.2.4.3.2.7 Transfection Reagents
          • 12.2.4.3.2.8 End User
      • 12.2.4.4 Italy Market
        • 12.2.4.4.1 Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.4.2 Italy: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.4.2.1 Type
          • 12.2.4.4.2.2 Cell Therapy For Type
          • 12.2.4.4.2.3 Gene Therapy For Type
          • 12.2.4.4.2.4 Service
          • 12.2.4.4.2.5 Scale
          • 12.2.4.4.2.6 Service Providers
          • 12.2.4.4.2.7 Transfection Reagents
          • 12.2.4.4.2.8 End User
      • 12.2.4.5 Spain Market
        • 12.2.4.5.1 Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.5.2 Spain: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.5.2.1 Type
          • 12.2.4.5.2.2 Cell Therapy For Type
          • 12.2.4.5.2.3 Gene Therapy For Type
          • 12.2.4.5.2.4 Service
          • 12.2.4.5.2.5 Scale
          • 12.2.4.5.2.6 Service Providers
          • 12.2.4.5.2.7 Transfection Reagents
          • 12.2.4.5.2.8 End User
      • 12.2.4.6 Rest of Europe Market
        • 12.2.4.6.1 Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.2.4.6.2 Rest of Europe: Cell and Gene Therapy Market- By Segmentation
          • 12.2.4.6.2.1 Type
          • 12.2.4.6.2.2 Cell Therapy For Type
          • 12.2.4.6.2.3 Gene Therapy For Type
          • 12.2.4.6.2.4 Service
          • 12.2.4.6.2.5 Scale
          • 12.2.4.6.2.6 Service Providers
          • 12.2.4.6.2.7 Transfection Reagents
          • 12.2.4.6.2.8 End User
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Cell and Gene Therapy Market Overview
    • 12.3.2 Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.3.3 Asia Pacific: Cell and Gene Therapy Market- By Segmentation
      • 12.3.3.1 Type
      • 12.3.3.2 Cell Therapy For Type
      • 12.3.3.3 Gene Therapy For Type
      • 12.3.3.4 Service
      • 12.3.3.5 Scale
      • 12.3.3.6 Service Providers
      • 12.3.3.7 Transfection Reagents
      • 12.3.3.8 End User
    • 12.3.4 Asia Pacific: Cell and Gene Therapy Market Breakdown by Countries
      • 12.3.4.1 China Market
        • 12.3.4.1.1 China: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.1.2 China: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.1.2.1 Type
          • 12.3.4.1.2.2 Cell Therapy For Type
          • 12.3.4.1.2.3 Gene Therapy For Type
          • 12.3.4.1.2.4 Service
          • 12.3.4.1.2.5 Scale
          • 12.3.4.1.2.6 Service Providers
          • 12.3.4.1.2.7 Transfection Reagents
          • 12.3.4.1.2.8 End User
      • 12.3.4.2 Japan Market
        • 12.3.4.2.1 Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.2.2 Japan: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.2.2.1 Type
          • 12.3.4.2.2.2 Cell Therapy For Type
          • 12.3.4.2.2.3 Gene Therapy For Type
          • 12.3.4.2.2.4 Service
          • 12.3.4.2.2.5 Scale
          • 12.3.4.2.2.6 Service Providers
          • 12.3.4.2.2.7 Transfection Reagents
          • 12.3.4.2.2.8 End User
      • 12.3.4.3 India Market
        • 12.3.4.3.1 India: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.3.2 India: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.3.2.1 Type
          • 12.3.4.3.2.2 Cell Therapy For Type
          • 12.3.4.3.2.3 Gene Therapy For Type
          • 12.3.4.3.2.4 Service
          • 12.3.4.3.2.5 Scale
          • 12.3.4.3.2.6 Service Providers
          • 12.3.4.3.2.7 Transfection Reagents
          • 12.3.4.3.2.8 End User
      • 12.3.4.4 Australia Market
        • 12.3.4.4.1 Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.4.2 Australia: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.4.2.1 Type
          • 12.3.4.4.2.2 Cell Therapy For Type
          • 12.3.4.4.2.3 Gene Therapy For Type
          • 12.3.4.4.2.4 Service
          • 12.3.4.4.2.5 Scale
          • 12.3.4.4.2.6 Service Providers
          • 12.3.4.4.2.7 Transfection Reagents
          • 12.3.4.4.2.8 End User
      • 12.3.4.5 South Korea Market
        • 12.3.4.5.1 South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.5.2 South Korea: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.5.2.1 Type
          • 12.3.4.5.2.2 Cell Therapy For Type
          • 12.3.4.5.2.3 Gene Therapy For Type
          • 12.3.4.5.2.4 Service
          • 12.3.4.5.2.5 Scale
          • 12.3.4.5.2.6 Service Providers
          • 12.3.4.5.2.7 Transfection Reagents
          • 12.3.4.5.2.8 End User
      • 12.3.4.6 Rest of APAC Market
        • 12.3.4.6.1 Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.3.4.6.2 Rest of APAC: Cell and Gene Therapy Market- By Segmentation
          • 12.3.4.6.2.1 Type
          • 12.3.4.6.2.2 Cell Therapy For Type
          • 12.3.4.6.2.3 Gene Therapy For Type
          • 12.3.4.6.2.4 Service
          • 12.3.4.6.2.5 Scale
          • 12.3.4.6.2.6 Service Providers
          • 12.3.4.6.2.7 Transfection Reagents
          • 12.3.4.6.2.8 End User
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Cell and Gene Therapy Market Overview
    • 12.4.2 Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.4.3 Middle East and Africa: Cell and Gene Therapy Market- By Segmentation
      • 12.4.3.1 Type
      • 12.4.3.2 Cell Therapy For Type
      • 12.4.3.3 Gene Therapy For Type
      • 12.4.3.4 Service
      • 12.4.3.5 Scale
      • 12.4.3.6 Service Providers
      • 12.4.3.7 Transfection Reagents
      • 12.4.3.8 End User
    • 12.4.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown by Countries
      • 12.4.4.1 Saudi Arabia Market
        • 12.4.4.1.1 Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.1.2 Saudi Arabia: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.1.2.1 Type
          • 12.4.4.1.2.2 Cell Therapy For Type
          • 12.4.4.1.2.3 Gene Therapy For Type
          • 12.4.4.1.2.4 Service
          • 12.4.4.1.2.5 Scale
          • 12.4.4.1.2.6 Service Providers
          • 12.4.4.1.2.7 Transfection Reagents
          • 12.4.4.1.2.8 End User
      • 12.4.4.2 South Africa Market
        • 12.4.4.2.1 South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.2.2 South Africa: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.2.2.1 Type
          • 12.4.4.2.2.2 Cell Therapy For Type
          • 12.4.4.2.2.3 Gene Therapy For Type
          • 12.4.4.2.2.4 Service
          • 12.4.4.2.2.5 Scale
          • 12.4.4.2.2.6 Service Providers
          • 12.4.4.2.2.7 Transfection Reagents
          • 12.4.4.2.2.8 End User
      • 12.4.4.3 United Arab Emirates Market
        • 12.4.4.3.1 United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.3.2 United Arab Emirates: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.3.2.1 Type
          • 12.4.4.3.2.2 Cell Therapy For Type
          • 12.4.4.3.2.3 Gene Therapy For Type
          • 12.4.4.3.2.4 Service
          • 12.4.4.3.2.5 Scale
          • 12.4.4.3.2.6 Service Providers
          • 12.4.4.3.2.7 Transfection Reagents
          • 12.4.4.3.2.8 End User
      • 12.4.4.4 Rest of Middle East and Africa Market
        • 12.4.4.4.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.4.4.4.2 Rest of Middle East and Africa: Cell and Gene Therapy Market- By Segmentation
          • 12.4.4.4.2.1 Type
          • 12.4.4.4.2.2 Cell Therapy For Type
          • 12.4.4.4.2.3 Gene Therapy For Type
          • 12.4.4.4.2.4 Service
          • 12.4.4.4.2.5 Scale
          • 12.4.4.4.2.6 Service Providers
          • 12.4.4.4.2.7 Transfection Reagents
          • 12.4.4.4.2.8 End User
  • 12.5 South and Central America
    • 12.5.1 South and Central America Cell and Gene Therapy Market Overview
    • 12.5.2 South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 12.5.3 South and Central America: Cell and Gene Therapy Market- By Segmentation
      • 12.5.3.1 Type
      • 12.5.3.2 Cell Therapy For Type
      • 12.5.3.3 Gene Therapy For Type
      • 12.5.3.4 Service
      • 12.5.3.5 Scale
      • 12.5.3.6 Service Providers
      • 12.5.3.7 Transfection Reagents
      • 12.5.3.8 End User
    • 12.5.4 South and Central America: Cell and Gene Therapy Market Breakdown by Countries
      • 12.5.4.1 Brazil Market
        • 12.5.4.1.1 Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.1.2 Brazil: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.1.2.1 Type
          • 12.5.4.1.2.2 Cell Therapy For Type
          • 12.5.4.1.2.3 Gene Therapy For Type
          • 12.5.4.1.2.4 Service
          • 12.5.4.1.2.5 Scale
          • 12.5.4.1.2.6 Service Providers
          • 12.5.4.1.2.7 Transfection Reagents
          • 12.5.4.1.2.8 End User
      • 12.5.4.2 Argentina Market
        • 12.5.4.2.1 Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.2.2 Argentina: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.2.2.1 Type
          • 12.5.4.2.2.2 Cell Therapy For Type
          • 12.5.4.2.2.3 Gene Therapy For Type
          • 12.5.4.2.2.4 Service
          • 12.5.4.2.2.5 Scale
          • 12.5.4.2.2.6 Service Providers
          • 12.5.4.2.2.7 Transfection Reagents
          • 12.5.4.2.2.8 End User
      • 12.5.4.3 Rest of South and Central America Market
        • 12.5.4.3.1 Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 12.5.4.3.2 Rest of South and Central America: Cell and Gene Therapy Market- By Segmentation
          • 12.5.4.3.2.1 Type
          • 12.5.4.3.2.2 Cell Therapy For Type
          • 12.5.4.3.2.3 Gene Therapy For Type
          • 12.5.4.3.2.4 Service
          • 12.5.4.3.2.5 Scale
          • 12.5.4.3.2.6 Service Providers
          • 12.5.4.3.2.7 Transfection Reagents
          • 12.5.4.3.2.8 End User

13. Cell and Gene Therapy Market Industry Landscape

14. Cell and Gene Therapy Market - Key Company Profiles

  • 14.1 CRISPR Therapeutics
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Cell Therapys and Gene Therapy
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Horizon Discovery Group plc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Cell Therapys and Gene Therapy
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Cell Therapys and Gene Therapy
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Cell Therapys and Gene Therapy
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Integrated DNA Technologies Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Cell Therapys and Gene Therapy
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 QIAGEN NV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Cell Therapys and Gene Therapy
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Takara Bio Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Cell Therapys and Gene Therapy
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Synthego Holdings LLC
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Cell Therapys and Gene Therapy
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GenScript Biotech Corporation
    • 14.9.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Cell Therapys and Gene Therapy
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Editas Medicine Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Cell Therapys and Gene Therapy
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary
  • 15.2 Research Methodology and Approach
    • 15.2.1 Secondary Research
    • 15.2.2 Primary Research
    • 15.2.3 Market Estimation Approach
      • 15.2.3.1 Supply Side Analysis
      • 15.2.3.2 Demand Side Analysis
    • 15.2.4 Research Assumptions and Limitations
    • 15.2.5 Currency Conversion
  • 15.3 About The Insight Partners
  • 15.4 Market Intelligence Cloud

List Of Tables

  • Table 1. Cell and Gene Therapy Market Segmentation
  • Table 2. List of Service Providers
  • Table 3. List of Potential Customers
  • Table 4. List of Patents and Description
  • Table 5. List of Regulatory Bodies and Organizations
  • Table 6. Ease of Doing Business: Key Country Rankings
  • Table 7. Market Share Analysis, 2024 - By Key Players
  • Table 8. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million)
  • Table 6. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million)
  • Table 7. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Type
  • Table 8. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Type
  • Table 9. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 10. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 11. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 12. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 13. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 14. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 15. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 16. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 17. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 18. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 19. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 20. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 21. Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 22. Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 23. North America: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 24. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 25. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 26. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 27. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 28. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 29. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 30. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 31. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 32. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 33. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 34. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 35. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 36. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 37. North America: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 38. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 39. North America: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 40. North America: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 41. United States: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 42. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 43. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 44. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 45. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 46. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 47. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 48. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 49. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 50. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 51. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 52. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 53. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 54. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 55. United States: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 56. United States: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 57. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 58. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 59. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 60. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 61. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 62. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 63. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 64. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 65. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 66. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 67. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 68. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 69. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 70. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 71. Canada: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 72. Canada: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 73. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 74. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 75. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 76. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 77. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 78. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 79. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 80. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 81. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 82. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 83. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 84. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 85. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 86. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 87. Mexico: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 88. Mexico: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 89. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 90. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 91. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 92. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 93. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 94. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 95. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 96. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 97. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 98. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 99. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 100. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 101. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 102. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 103. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 104. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 105. Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 106. Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 107. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 108. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 109. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 110. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 111. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 112. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 113. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 114. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 115. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 116. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 117. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 118. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 119. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 120. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 121. United Kingdom: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 122. United Kingdom: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 123. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 124. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 125. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 126. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 127. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 128. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 129. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 130. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 131. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 132. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 133. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 134. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 135. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 136. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 137. Germany: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 138. Germany: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 139. France: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 140. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 141. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 142. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 143. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 144. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 145. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 146. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 147. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 148. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 149. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 150. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 151. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 152. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 153. France: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 154. France: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 155. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 156. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 157. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 158. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 159. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 160. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 161. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 162. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 163. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 164. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 165. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 166. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 167. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 168. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 169. Italy: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 170. Italy: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 171. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 172. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 173. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 174. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 175. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 176. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 177. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 178. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 179. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 180. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 181. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 182. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 183. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 184. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 185. Spain: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 186. Spain: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 187. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 188. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 189. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 190. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 191. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 192. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 193. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 194. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 195. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 196. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 197. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 198. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 199. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 200. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 201. Rest of Europe: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 202. Rest of Europe: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 203. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 204. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 205. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 206. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 207. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 208. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 209. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 210. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 211. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 212. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 213. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 214. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 215. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 216. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 217. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 218. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 219. Asia Pacific: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 220. Asia Pacific: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 221. China: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 222. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 223. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 224. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 225. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 226. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 227. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 228. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 229. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 230. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 231. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 232. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 233. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 234. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 235. China: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 236. China: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 237. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 238. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 239. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 240. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 241. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 242. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 243. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 244. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 245. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 246. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 247. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 248. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 249. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 250. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 251. Japan: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 252. Japan: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 253. India: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 254. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 255. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 256. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 257. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 258. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 259. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 260. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 261. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 262. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 263. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 264. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 265. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 266. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 267. India: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 268. India: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 269. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 270. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 271. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 272. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 273. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 274. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 275. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 276. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 277. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 278. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 279. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 280. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 281. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 282. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 283. Australia: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 284. Australia: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 285. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 286. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 287. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 288. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 289. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 290. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 291. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 292. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service
  • Table 293. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Scale
  • Table 294. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Scale
  • Table 295. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service Providers
  • Table 296. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Providers
  • Table 297. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Transfection Reagents
  • Table 298. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Transfection Reagents
  • Table 299. South Korea: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 300. South Korea: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 301. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 302. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 303. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Cell Therapy for Type
  • Table 304. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Cell Therapy for Type
  • Table 305. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Gene Therapy for Type
  • Table 306. Rest of APAC: Cell and Gene Therapy Market - Revenue Forecast, 2025-2031(US$ Million) - by Gene Therapy for Type
  • Table 307. Rest of APAC: Cell and Gene Therapy Market - Revenue, 2021-2024(US$ Million) - by Service
  • Table 308. Rest of APAC: Cell and Gene T

List Of Figures

  • Figure 1. Cell and Gene Therapy Market - Value Chain Analysis
  • Figure 2. Pest Analysis
  • Figure 3. Cell and Gene Therapy Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • Figure 6. Cell and Gene Therapy Market Share (%) - by Type (2024 and 2031)
  • Figure 7. Cell Therapy: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 8. Gene Therapy: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 9. Cell and Gene Therapy Market Share (%) - by Service (2024 and 2031)
  • Figure 10. Process Development: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 11. cGMP Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 12. Regulatory Services: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 13. Bioassay Services: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 14. Cell and Gene Therapy Market Share (%) - by Scale (2024 and 2031)
  • Figure 15. Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 16. Commercial Scale Manufacturing: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 17. Cell and Gene Therapy Market Share (%) - by Service Providers (2024 and 2031)
  • Figure 18. CDMOs: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 19. CMOs: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 20. Cell and Gene Therapy Market Share (%) - by Transfection Reagents (2024 and 2031)
  • Figure 21. Polymer-based Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 22. Lipid-based Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 23. Viral Transduction Enhancers: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 24. Other Transfection Reagents: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 25. Cell and Gene Therapy Market Share (%) - by End User (2024 and 2031)
  • Figure 26. Contract Research Organizations: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 27. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 28. Academic and Research Institutes: Cell and Gene Therapy Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 29. Cell and Gene Therapy Market Breakdown by Geography, 2024 and 2031
  • Figure 30. North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 31. North America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 32. United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 33. Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 34. Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 35. Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 36. Europe: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 37. United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 38. Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 39. France: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 40. Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 41. Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 42. Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 43. Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 44. Asia Pacific: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 45. China: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 46. Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 47. India: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 48. Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 49. South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 50. Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 51. Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 52. Middle East and Africa: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 54. South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 59. Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 60. Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 61. Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 62. Bottom-Up Approach and Top-Down Approach